Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Outer membrane protein PorA is a major surface-exposed porin found in Neisseria species, most notably Neisseria meningitidis, where it serves as a critical component of the bacterial outer membrane [1, 3]. Structurally, it forms a trimeric beta-barrel that functions as a cation-selective channel, facilitating the transport of essential nutrients while maintaining membrane integrity [3, 8]. Beyond its physiological role, PorA is a potent immunogen and a primary target for the host's bactericidal immune response [2, 11]. It is a key antigen in several licensed and experimental vaccines, particularly those targeting serogroup B meningococci, such as the outer membrane vesicle (OMV) component of Bexsero [6, 10]. In the context of disease, PorA contributes to the pathogenesis of invasive meningococcal disease, including meningitis and sepsis, by mediating adhesion to host cells and facilitating immune evasion [1, 5]. The protein exhibits significant antigenic diversity, primarily localized within two variable regions (VR1 and VR2), which allows the bacteria to escape recognition by existing antibodies [5, 12]. This high degree of variability and the potential for phase variation present major challenges for the development of universal vaccines, often requiring "tailor-made" or multi-antigen formulations to ensure broad coverage [2, 11]. Therapeutic strategies focus on inducing high titers of serum bactericidal antibodies (SBA) that trigger complement-mediated lysis of the pathogen [6, 7]. Additionally, PorA is used as a primary marker for the serosubtyping of meningococcal strains in epidemiological surveillance [5, 9].
Induction of serum bactericidal antibodies (SBA) leading to complement-mediated bacterial lysis
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Outer membrane protein PorA (PorA).